CB
Cascade Biocatalysts, Inc.
SEC filingBiotechnology · Denver, CO
Amount raised$5.4Msold at filing
Total offering$5.6M$175K still open
Investors in the raise41count reported to the SEC
FiledAug 25, 2025first sale Aug 8, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alexander RosayExecutive Officer, Director, Promoter
James WeltzExecutive Officer, Director, Promoter
Jared CampbellDirector
Executive officers, directors and promoters as listed on the Form D.